Mikrogen GmbH

Company

    • Company type:
      • Manufacturer
      • Research & Development
    • Year founded:
    • 1989
    • Employees (at the site):
    • 115
    • Turnover range:
    • 5m - <10m EUR
    • Products/services:
    • Clinical Diagnostics, ELISA / EIA, Infectious Diseases

    • Core competencies:
    • Founded 1989, Mikrogen's business scope covers the development of new diagnostic test systems based on recombinant antigens, especially immunoblots and ELISAs using recombinant antigens. Major products are test kits for the detection of antibodies against Borrelia burgdorferi, Yersinia enterocolitica, Helicobacter pylori, Rubella Virus, Parvovirus B19, HIV 1/2 or Epstein Barr Virus. Especially on Parvovirus B19 and Borrelia burgdorferi, Mikrogen holds several patents and patent applications covering the antigens. The company aims to expand the available test systems by adding new parameters.

    • Language skills:
    • English
      German
    • Key Tech / section:
      • Biotechnology: Molecular diagnostics for humans
    • Certification:
    • not available

    • Sales markets - target industries:
    • not available
    • Sales markets - target countries:
    • not available
    • Cooperation offers:
    • not available
    • Contact person:
    • Dr. Erwin Soutschek (Mr.)
      - Management